Phase II Study of R115777 for the Treatment of Adults With Newly Diagnosed Glioblastoma Multiforme
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2013
At a glance
- Drugs Tipifarnib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.